Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Fulvestrant combined with Pyrotinib|DRUG: Capecitabine combined with Pyrotinib
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University